36 participants
Safety, Immunogenicity and Dose Response of ATH03, a New Vaccine Against the Cholesterol Ester Transfer Protein (CETP)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2012-10-05
- Start Date:
- 2011-05-31
- Completion:
- 2012-07-31
Conditions
- HDL
- Drug Safety
Interventions
- BIOLOGICAL
No Results Yet